NDC 70771-1691
pemetrexed
Pemetrexed Disodium
pemetrexed is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Pemetrexed Disodium.
| Product ID | 70771-1691_fc5f4aa1-92c4-444b-8e64-53708c9a67bc |
| NDC | 70771-1691 |
| Product Type | Human Prescription Drug |
| Proprietary Name | pemetrexed |
| Generic Name | Pemetrexed Disodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-05-26 |
| Marketing Category | ANDA / |
| Application Number | ANDA214073 |
| Labeler Name | Zydus Lifesciences Limited |
| Substance Name | PEMETREXED DISODIUM |
| Active Ingredient Strength | 100 mg/4mL |
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |